Search
for
Sort by
Research 151–180 of 1000+
- Dissecting Cellulitis of the Scalp Successfully Treated with a Combination of Ixekizumab and Tofacitinib
- Characterizing Lipid Changes and Use of Lipid-Lowering Medications in Patients With Alopecia Areata Treated With Baricitinib: Integrated Results From the BRAVE-AA1 and -AA2 Clinical Trials
- Treatment of longstanding alopecia areata universalis of the eyebrows/facial hair with oral and topical tofacitinib
- JAK Inhibitors in the Treatment of Alopecia Areata: Efficacy, Safety, and Long-term Outcomes
- Ruxolitinib 1.5% Topical Cream for the Treatment of Pediatric Alopecia Areata
- A Nationwide Outbreak of Alopecia Associated With the Use of a Hair-Relaxing Formulation
- 519 Phase I/IIa clinical trial for recessive dystrophic epidermolysis bullosa using genetically corrected autologous keratinocytes
- Sorafenib-induced Facial Acneiform Eruption
- Clinical and Haematological Improvement Following a 90-Day Oral Iron Supplementation Regimen in Adults with Iron Deficiency Anemia - A Prospective Real-World Observational Study
- Long‐Term Use of Tralokinumab in Patients With Atopic Dermatitis: A Real‐World Multicentric Case Series
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial
- Duration of current alopecia areata episode predicts the effectiveness of baricitinib in Japanese patients with alopecia areata: a single-center retrospective study
- Efficacy and Safety of Biologic Therapies for Treatment of Psoriasis: A Systematic Review and Observational Meta-Analysis
- P0881 Effectiveness and Safety of Tofacitinib in Biologic-Naïve Elderly Patients with Ulcerative Colitis
- Efficacy and safety of tofacitinib in pediatric patients with alopecia areata: A prospective cohort study
- Ritlecitinib Efficacy in Adolescents With Alopecia Areata: A Real‐World Experience
- Ritlecitinib in Alopecia Areata: A 24‐Week Real‐World Experience Contrasting JAK Inhibitor‐Naïve and JAK Inhibitor‐Experienced Patients
- Systematic review and indirect treatment comparisons of ritlecitinib against baricitinib in alopecia areata
- Real‐world effectiveness and safety of tofacitinib for alopecia areata: A retrospective cohort study of 202 patients
- Les Rencontres d’Experts du Psoriasis : des recommandations pour la pratique quotidienne
- Association of prior 5-α-reductase inhibitor exposure with ICI benefit in metastatic RCC: Multicentre cohort with single-cell immune profiling.
- Real‐life effectiveness and safety of baricitinib in adults with alopecia areata: A multicentre study
- Effectiveness and safety of the ablative fractional 2940-nm Er: YAG laser for the treatment of androgenetic alopecia
- Dutasteride
- Biologic Therapies and Small-Molecule Inhibitors for Dissecting Cellulitis of the Scalp: A Systematic Review
- Comprehensive Safety Exposure‐Response Analysis to Support Ritlecitinib Dose Selection
- Abstract P5-11-11: A phase I safety study of topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA)
- Exploring novel management options for alopecia areata
- Type 2 Diabetes, Metabolic Syndrome and Lipid Metabolism